ORGJF(ORGJF)
ORGJF
No analyst ratings available
No analyst price targets available for ORGJF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $205.52B | $234.45B | $259.14B |
| Low | $201.59B | $220.56B | $248.68B |
| High | $211.67B | $255.07B | $274.86B |
| EBITDA Avg | $44.77B | $51.75B | $56.37B |
| Low | $42.55B | $49.18B | $53.57B |
| High | $48.11B | $55.62B | $60.58B |
| EBIT Avg | $42.56B | $49.28B | $53.62B |
| Low | $40.34B | $46.71B | $50.82B |
| High | $45.90B | $53.14B | $57.82B |
| Net Income Avg | $31.11B | $36.05B | $39.24B |
| Low | $29.48B | $34.16B | $37.18B |
| High | $33.56B | $38.89B | $42.33B |
| EPS Avg | $676.59 | $784.02 | $853.41 |
| Low | $641.08 | $742.88 | $808.62 |
| High | $729.95 | $845.86 | $920.72 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $51.38B | $52.25B | $59.37B | $48.38B | $58.46B | $53.42B | $73.58B |
| Low | $49.03B | $49.27B | $56.34B | $45.91B | $55.47B | $50.69B | $69.82B |
| High | $55.56B | $55.04B | $63.40B | $51.67B | $62.43B | $57.05B | $78.58B |
| EBITDA Avg | $11.08B | $11.50B | $16.47B | — | — | — | — |
| Low | $10.39B | $10.78B | $15.41B | — | — | — | — |
| High | $12.01B | $12.47B | $17.86B | — | — | — | — |
| EBIT Avg | $10.58B | $10.98B | $15.93B | — | — | — | — |
| Low | $9.88B | $10.26B | $14.88B | — | — | — | — |
| High | $11.50B | $11.95B | $17.33B | — | — | — | — |
| Net Income Avg | $7.72B | $8.01B | $11.65B | — | — | — | — |
| Low | $7.20B | $7.48B | $10.88B | — | — | — | — |
| High | $8.40B | $8.72B | $12.68B | — | — | — | — |
| EPS Avg | $167.79 | $174.29 | $253.36 | — | — | — | — |
| Low | $156.65 | $162.72 | $236.53 | — | — | — | — |
| High | $182.60 | $189.68 | $275.72 | — | — | — | — |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — | 1 / — |